Your browser doesn't support javascript.
loading
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial.
Liu, Joyce F; Herold, Christina; Gray, Kathryn P; Penson, Richard T; Horowitz, Neil; Konstantinopoulos, Panagiotis A; Castro, Cesar M; Hill, Sarah J; Curtis, Jennifer; Luo, Weixiu; Matulonis, Ursula A; Cannistra, Stephen A; Dizon, Don S.
Afiliação
  • Liu JF; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Herold C; Division of Breast Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gray KP; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Penson RT; Department of Medical Oncology, Massachusetts General Hospital, Boston.
  • Horowitz N; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Konstantinopoulos PA; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Castro CM; Department of Medical Oncology, Massachusetts General Hospital, Boston.
  • Hill SJ; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Curtis J; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Luo W; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Matulonis UA; Division of Gynecologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cannistra SA; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Dizon DS; Department of Medical Oncology, Massachusetts General Hospital, Boston.
JAMA Oncol ; 5(12): 1731-1738, 2019 12 01.
Article em En | MEDLINE | ID: mdl-31600397
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Carcinoma Epitelial do Ovário / Nivolumabe / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Bevacizumab / Carcinoma Epitelial do Ovário / Nivolumabe / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article